Evaluation of the Application Effect of Enteral and Parenteral Nutrition Therapy Combined with a Health Belief Education Model in Patients with Inflammatory Bowel Disease

Abstract

Objective: To evaluate the application effect of enteral and parenteral nutrition therapy combined with a health belief education model in patients with inflammatory bowel disease. Methods: 80 patients with inflammatory bowel disease admitted to the Shanghai Zhangjiang Institute of Medical Innovation were chosen. This study was carried out from August 2022 to October 2023. The patients were randomly divided into a study group (40 cases) and a control group (40 cases). The treatment plan for the control group was the conventional treatment model, while the treatment plan for the study group was to provide enteral and parenteral nutrition therapy combined with a health belief education model based on the control group. The efficacy of both groups was compared. Results: In the study group, the therapeutic effect for 31 patients (77.50%) was markedly effective and 7 was effective (17.50%), accounting for 95.0% of the total, which was higher than the control group at 80.0% (P < 0.05). The relief time of relevant symptoms in the study group was shorter than that of the control group (P < 0.05). Before treatment, there were no differences in the high-sensitivity C-reactive protein (hs-CRP), interleukin 10 (IL-10), and tumor necrosis factor- α (TNF-α) between both groups (P > 0.05). After treatment, the levels of inflammatory factors in the study group (hs-CRP (8.02 ± 1.13) mg/L, IL -10 (9.24 ± 1.25) pg/mL, and TNF-α (7.19 ± 1.04) ng/L) were lower than those in the control group (P < 0.05). Conclusion: Enteral and parenteral nutritional therapy combined with a health belief education model showed significant efficacy in inflammatory bowel disease patients. Patient symptoms were relieved and inflammatory reactions were reduced. This method is worthy of popularization.